title: Suppression of insulin secretion by C-peptide infusion in humans.
abstract: A role for insulin in the regulation of its own secretion has been established; however, no such effect of C-peptide has been demonstrated. In order to reexamine the role of C-peptide and insulin in regulating beta cell secretion, we infused C-peptide as a primed continuous infusion of 1 ng/min per kg for 45 min to 7 healthy volunteers, and insulin in a similar manner at rates of 1 and 10 mU/min per kg for 2 h to 14 healthy subjects using the euglycemic insulin clamp technique. Plasma insulin and C-peptide were measured before and during the infusions. During C-peptide infusion, C-peptide levels rose from 1.8 +/- 0.2 to 2.3 +/- 0.2 ng/ml, and insulin levels fell from 14.5 +/- 0.8 to 11.0 +/- 1.0 microU/ml (P < 0.01). During low and high rate insulin infusions, insulin levels rose to 70 +/- 8 and 1,020 +/- 105 microU/ml, while C-peptide levels fell significantly from 1.9 +/- 0.2 to 1.5 +/- 0.2 and to 1.3 +/- 0.1 ng/ml, respectively. Thus 5- and 70-fold increases in circulating insulin levels caused 15% and 33% drops in serum C-peptide, respectively. However, a 30% increase in C-peptide levels caused a significant approximately 24% decrease in the levels of plasma insulin. We conclude that insulin induces a dose-dependent inhibition of beta cell secretion, which is even more sensitive to inhibition by C-peptide. These data suggest a physiological role for C-peptide in regulating human insulin secretion in vivo.
authors.affiliation: Metabolic Unit, Rambam Medical Center, Haifa, Israel.
authors.forename: P
authors.initials: P
authors.lastname: Cohen
authors.forename: N
authors.initials: N
authors.lastname: Barzilai
authors.forename: E
authors.initials: E
authors.lastname: Karnieli
mesh_terms: D000328:Adult; D002096:C-Peptide / Q000008:administration & dosage / Q000494:pharmacology*; D004305:Dose-Response Relationship, Drug; D004341:Drug Evaluation; D005260:Female; D015309:Glucose Clamp Technique; D006706:Homeostasis; D006801:Humans; D007262:Infusions, Intravenous; D007328:Insulin / Q000378:metabolism*; D007329:Insulin Antagonists / Q000008:administration & dosage / Q000494:pharmacology*; D000078790:Insulin Secretion; D007515:Islets of Langerhans / Q000187:drug effects / Q000378:metabolism; D008297:Male
chemical_list: D002096:C-Peptide; D007328:Insulin; D007329:Insulin Antagonists